Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

(S, R, S) -AHPC-Me-C6-NH2

(S, R, S) -AHPC-Me-C6-NH2 can be used for the synthesis of PROTAC[1]. (S, R, S) -AHPC-Me-C6-NH2 (Compound SI-9) contains VHL ligand 2 (HY-112078) [2].

Product Specifications

CAS Number

[2411422-49-4]

UNSPSC

12352005

Target

E3 Ligase Ligand-Linker Conjugates

Type

Reference compound

Related Pathways

PROTAC

Applications

Cancer-programmed cell death

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/s-r-s-ahpc-me-c6-nh2.html

Purity

99.81

Solubility

DMSO : ≥ 100 mg/mL

Smiles

NCCCCCCC(N[C@@H](C(C)(C)C)C(N1[C@@H](C[C@H](C1)O)C(N[C@H](C2=CC=C(C3=C(N=CS3)C)C=C2)C)=O)=O)=O

Molecular Formula

C30H45N5O4S

Molecular Weight

571.77

References & Citations

[1]Haibing Zhou, et al. Oseltamivir PROTAC compound, preparation method thereof and application thereof in anti-influenza virus drugs. Patent CN112592331A.|[2]Bondeson DP, et al. Systematic profiling of conditional degron tag technologies for target validation studies. Nat Commun. 2022 Sep 20;13 (1) :5495.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

Lentiviral mouse Safb2 shRNA (UAS) - Lentiviral mouse Safb2 shRNA (UAS, GFP) plasmid
GTR15272026 1 Vial

Lentiviral mouse Safb2 shRNA (UAS) - Lentiviral mouse Safb2 shRNA (UAS, GFP) plasmid

Sign In for Pricing
View Details
SLC1A4 (Solute Carrier Family 1 Member 4, ASCT1, SATT) (PE)
MBS6437792-01 0.1 mL

SLC1A4 (Solute Carrier Family 1 Member 4, ASCT1, SATT) (PE)

Sign In for Pricing
View Details
SLC1A4 (Solute Carrier Family 1 Member 4, ASCT1, SATT) (PE)
MBS6437792-02 5x 0.1 mL

SLC1A4 (Solute Carrier Family 1 Member 4, ASCT1, SATT) (PE)

Sign In for Pricing
View Details
NALP4 (NACHT-, LRR-and PYD-containing Protein 4, NACHT Leucine Rich Repeat and PYD Containing 4, CLR19.5, FLJ32126, Nucleotide Binding Oligomerization Domain Leucine Rich Repeat and Pyrin Domain Containing 4, NLR Family Pyrin Domain Containing 4, NLRP4, PAAD and NACHT Containing Protein 2, PAN2, PYRIN Containing APAF1-like Protein 4, PYPAF4, Ribonuclease Inhibitor 2, RNH2)
146720 100 µg

NALP4 (NACHT-, LRR-and PYD-containing Protein 4, NACHT Leucine Rich Repeat and PYD Containing 4, CLR19.5, FLJ32126, Nucleotide Binding Oligomerization Domain Leucine Rich Repeat and Pyrin Domain Containing 4, NLR Family Pyrin Domain Containing 4, NLRP4, PAAD and NACHT Containing Protein 2, PAN2, PYRIN Containing APAF1-like Protein 4, PYPAF4, Ribonuclease Inhibitor 2, RNH2)

Sign In for Pricing
View Details
Human hsa-miR-4649-5p miRNA Agomir
abx881445-01 5 nmol

Human hsa-miR-4649-5p miRNA Agomir

Sign In for Pricing
View Details
Human hsa-miR-4649-5p miRNA Agomir
abx881445-02 10 nmol

Human hsa-miR-4649-5p miRNA Agomir

Sign In for Pricing
View Details